UBS AM’s BioRestorative Therapies BRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2 Buy
+1
New +$5 ﹤0.01% 4245

Other funds holding BRTX

UBS AM's BRTX Position: Q3 2026 in Review

UBS AM opened a new position in BioRestorative Therapies (BRTX) in Q3 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #4245 among its holdings.

12 funds tracked by Wall St. Rank hold BRTX as of Q3 2026.

  • UBS AM held 1 share of BioRestorative Therapies worth $2 as of Q3 2026.
  • BioRestorative Therapies was a new UBS AM position in Q3 2026.
  • BioRestorative Therapies made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4245 holding.
  • 12 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.